Japanese Journal of Clinical Oncology, Vol 27, Issue 5 350-352, Copyright © 1997 by Foundation for Promotion of Cancer Research
K Nasu, K Arima, J Yoshimatsu and I Miyakawa
We report a case of adenomyomatous polyp that developed during treatment
with tamoxifen for breast cancer. A 63-year-old Japanese woman was admitted
complaining of atypical genital bleeding. Nine months earlier, she had
undergone a modified radical mastectomy for cancer of her right breast,
estrogen receptor-positive stage I (T1N0M0). The administration of
tamoxifen, 20 mg/day, was started immediately postoperatively. Pelvic
examination after tamoxifen administration for 9 months revealed that the
uterus was enlarged to the size of a fist. Transvaginal ultrasonography and
magnetic resonance imaging revealed a large solid mass with multiple cystic
areas in the uterine cavity. The pathological diagnosis of the tumor after
total hysterectomy was typical adenomyomatous polyp. It was believed to
have developed during tamoxifen administration.
ORIGINAL ARTICLE
Adenomyomatous polyp of the uterus in a patient receiving tamoxifen
Department of Obstetrics and Gynecology, Oita Medical University, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. J. Lee, J. H. Han, and H. S. Ryu Polypoid Adenomyomas: Sonohysterographic and Color Doppler Findings With Histopathologic Correlation J. Ultrasound Med., November 1, 2004; 23(11): 1421 - 1429. [Abstract] [Full Text] [PDF] |
||||
